SCHEMBL778396

SCHEMBL778396

CC(C)(C)OS(=O)(=O)OC(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.31
TSHR P16473 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL776325 0.96
Nitrous Acid SCHEMBL27574628 0.85 ALDH1A1 (0.35) ALDH1A1
SCHEMBL9980980 0.83 USP2 (0.37) TSHRALDH1A1
Ammonia Solution, Strong SCHEMBL27623894 0.81 USP2 (0.35) TSHRALDH1A1
Fluoride SCHEMBL779013 0.81 USP2 (0.35) TSHRALDH1A1
SCHEMBL24067562 0.81
SCHEMBL18632049 0.81
SCHEMBL9295743 0.78 TSHR (0.37) TDP1TSHR
SCHEMBL17466345 0.76
SCHEMBL17466413 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115124446-A Purification method of di-tert-butyl peroxide 常熟市滨江化工有限公司 2022-09-30 CN claimed
CN-109734062-B Preparation method of difluorosulfonyl imide acid 江苏华盛锂电材料股份有限公司 2022-02-25 CN claimed
US-9453244-B2 Method for producing a monoalkene by enzymatic conversion of an alkyl monoester GLOBAL BIOENERGIES (FR) 2016-09-27 US claimed
US-20150159177-A1 METHOD FOR PRODUCING A MONOALKENE BY ENZYMATIC CONVERSION OF AN ALKYL MONOESTER GLOBAL BIOENERGIES (FR) 2015-06-11 US claimed
US-8460821-B2 Non-aqueous electrolyte secondary battery, non-aqueous electrolyte, and method for fabricating non-aqueous electrolyte secondary battery GS YUASA INTERNATIONAL LTD. (JP) 2013-06-11 US claimed
US-20110318655-A1 NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY, NON-AQUEOUS ELECTROLYTE, AND METHOD FOR FABRICATNG NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY GS YUASA INTERNATIONAL LTD. (JP) 2011-12-29 US claimed
US-12555823-B2 Electrolyte solution and method for producing sulfate salt DAIKIN INDUSTRIES, LTD. (JP) 2026-02-17 US disclosed
CN-120040335-A Indoxyl sulfate derivative, immunogen, antibody and detection reagent preparation and application 胥江生物科技(苏州)有限公司 2025-05-27 CN disclosed
WO-2024248572-A1 SUSTAINED-RELEASE MICROSPHERE PREPARATION COMPRISING TIRZEPATIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PREPARING SAME 주식회사 지투지바이오 2024-12-05 WO disclosed
CN-221808565-U Device for precisely removing sulfur dioxide from isobutene 宁波章甫能源科技有限公司 2024-10-08 CN disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
CN-112574084-B Waste liquid treatment process and device in TPO production process 山东久日化学科技有限公司 2024-08-23 CN disclosed
CN-118022498-A Device and method for isobutene fine desulfurization and waste alkali liquid treatment 宁波章甫能源科技有限公司 2024-05-14 CN disclosed
US-5948125-A Method of treating dyed, natural or synthetic polyamide fibre materials CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-09-07 US disclosed
EP-0245835-B1 NOVEL THIOPHENE DERIVATIVES AND METHODS FOR PRODUCING THE SAME SEITETSU KAGAKU CO., LTD. (JP) 1993-05-05 EP disclosed
US-5101049-A Novel thiophene derivatives and methods for producing the same SEITETSU KAGAKU CO., LTD. (JP) 1992-03-31 US disclosed
US-4792612-A MEDICINE INTERMEDIATES SEITETSU KAGAKU CO., LTD. (JP) 1988-12-20 US disclosed
EP-0245835-A2 Novel thiophene derivatives and methods for producing the same SEITETSU KAGAKU CO., LTD. (JP) 1987-11-19 EP disclosed
EP-0045429-B1 PROCESS FOR THE PREPARATION OF 4-TERT. BUTYLBENZALDEHYDES BAYER AG (DE) 1983-08-31 EP disclosed
US-3950442-A HYDRATION OF ISOBUTYLENE BASF AKTIENGESELLSCHAFT (DT) 1976-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12555823-B2 Electrolyte solution and method for producing sulfate salt SLC6A11, SLC26A3, SLC5A11 TDP1 4790/4885TSHR 745/4885ALDH1A1 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.